nily

GLP-1 support before, during and between clinical reviews

A prescription is one part of a weight-management pathway—not the entire pathway. Food tolerance, hydration, movement, sleep, medicine adherence, symptoms, current conditions and follow-up all affect whether the experience remains safe, manageable and aligned with professional advice.

Nily helps you prepare for an appropriate GLP-1 conversation and, if a qualified prescriber starts or continues treatment, maintain a clearer record between reviews. The program supports care; it does not replace the prescriber.

Check GLP-1 Consultation Readiness Explore Clinical Evaluation

An online checker, program enrolment, consultation or payment does not guarantee a prescription, medicine, dose, refill or weight-loss outcome.

Your prescription interest, symptoms and medicine information stay private and are never turned into advertising audiences or remarketing triggers.

What a GLP-1 support program means

A GLP-1 support program is the structured layer around a prescribed GLP-1 pathway—consultation preparation, adherence to the prescribed schedule, symptom and tolerance tracking, nutrition and hydration support, and follow-up preparation. It works alongside a valid prescription and a qualified prescriber; it does not choose a medicine, set a dose or replace clinical judgment.

Before you start: the decision facts

Availability
Digital support may be accessible nationally, but consultation, testing and fulfilment availability can vary by location. Check availability before payment.
Eligibility
Eligibility depends on an individual clinical evaluation by a qualified prescriber. No checker, payment or program enrolment confirms eligibility in advance.
Cost
Consultation, medicine, laboratory testing, nutrition support, program access and follow-up are shown as separate components, each with its own current price and scope. Check current pricing .
What's included
Consultation preparation, medication adherence tracking, symptom and tolerance recording, nutrition and hydration support, weight and metabolic context, and follow-up preparation.
Who this is not for
Anyone pregnant, breastfeeding or planning pregnancy; anyone with new or worsening symptoms who needs prompt professional or emergency care rather than a routine app review; and anyone expecting an automatic medicine choice or a guaranteed weight-loss result without individual clinical evaluation.

The right starting point depends on where you are now

I am considering a GLP-1 conversation

Use the readiness check to organize general history, current medicines, goals and safety context before deciding whether to access a qualified professional pathway. Start the GLP-1 Consultation-Readiness Check

I already have a valid prescription

Use the program to record medicine adherence, selected symptoms, appetite, hydration, routines, weight trends and questions for your next review. Follow the product instructions and your prescriber's advice.

I am having new or worsening symptoms

Do not wait for a routine app review. Contact the prescribing professional or seek urgent in-person care according to symptom severity and the medicine-specific instructions provided with your prescription.

I want weight-management support without assuming medicine

Explore the broader medical weight-management program, which begins with metabolic context and does not treat medicine as the default outcome. Explore Medical Weight Management

How the Nily GLP-1 pathway works

Step 1

Complete the consultation-readiness check

Organize relevant information before a clinical discussion. The result identifies areas to prepare; it does not confirm medical eligibility.

Step 2

Choose an appropriate clinical route

Where available, access the applicable consultation pathway. A professional may recommend no medicine, an in-person assessment, additional information or a different treatment approach. Explore GLP-1 Clinical Evaluation

Step 3

Record the prescribed plan accurately

If treatment is prescribed, store the medicine and plan exactly as directed. Nily must not independently generate a product substitution, titration schedule or refill instruction.

Step 4

Build supportive daily routines

Use practical routines around meals, hydration, movement, sleep and recovery that fit current tolerance, health context and professional advice.

Step 5

Track adherence and symptoms

Record when prescribed medicine was taken and selected symptoms or concerns. A tracker cannot prove that a medicine caused a symptom or determine whether a dose should change.

Step 6

Prepare for follow-up

Review trends, questions, missed doses, symptoms, current medicines and any available reports with the appropriate professional. Do not wait for a scheduled review if a safety concern requires earlier help.

What the GLP-1 support program is designed to include

Consultation preparation

Create a concise record of goals, history, medicines, previous weight-management attempts and questions for an individual clinical discussion.

Medication adherence tracking

Record the prescribed medicine plan and adherence without allowing the app to alter dose, timing or product. Explore Medication and Side-Effect Tracking

Symptom and tolerance record

Track selected gastrointestinal, appetite, hydration and general wellbeing signals so concerns are easier to describe during follow-up. Tracking is not a causality assessment or emergency monitor.

Nutrition and hydration support

Practical GLP-1 nutrition support starts with tolerance, not restriction. Use practical food and hydration routines aligned with current tolerance and applicable professional advice. Avoid extreme restriction or one imported diet chart for every person. Explore Nutrition Consultations

Weight and metabolic context

Review weight trends alongside energy, appetite, movement, sleep, symptoms and relevant health information instead of treating kilograms as the only outcome.
Explore Metabolic Health Tracking Explore Metabolic Lab Tests

Follow-up preparation

Bring the relevant longitudinal summary into the next professional conversation, subject to consent and appropriate access controls.

Questions about semaglutide side effects?

Medicine-specific side-effect questions are answered on a separately reviewed medicine guide, not folded into this program page.

A separately reviewed guide to semaglutide side effects is in preparation. Until it is published, discuss any side effect with your prescriber.

What the program does not provide

The Nily GLP-1 support program does not:

  • Sell a prescription based on an automated quiz.
  • Guarantee that a specific medicine is available or suitable.
  • Choose between medicines from marketing preferences or price alone.
  • Recommend a starting dose, dose increase, dose decrease or product substitution.
  • Instruct a user to repeat or skip a dose after an error.
  • Confirm that a symptom is caused by a medicine.
  • Replace an in-person examination, urgent care or the prescribing professional.
  • Promise a particular amount or pace of weight change.

Medicine-specific questions belong with the prescriber, pharmacist and current authorized product information.

Clinical context matters before and during treatment

An appropriately qualified prescriber may need to consider current conditions, pregnancy or pregnancy plans, breastfeeding, previous reactions, gastrointestinal history, other medicines, blood sugar treatment, relevant reports and other individual factors.

Do not omit medicines, supplements or health history because they appear unrelated. Do not use someone else's prescription or buy prescription medicine through an unverified social-media, messaging or marketplace seller.

If the professional determines that a GLP-1 pathway is not appropriate, Nily should route to a relevant alternative without implying failure.

Food, movement and muscle health remain part of the journey

GLP-1 support should not be reduced to eating as little as possible. The program should encourage a sustainable plan around food quality, adequate intake, hydration, movement, recovery and professional guidance appropriate to the individual.

Rapid or highly restrictive changes can create different risks for different people. Nily's public content must not prescribe a universal calorie, protein, fluid or exercise target.

Explore the Medical Weight Management Program

Know when not to wait for an app

Contact the prescribing professional promptly for new, persistent or worsening symptoms, medicine-use questions or concerns about the prescribed plan.

Seek urgent in-person or emergency care for severe or rapidly worsening symptoms, including severe abdominal pain, persistent vomiting or inability to keep fluids down, fainting, severe confusion, breathing difficulty or signs of a serious allergic reaction. Follow the medicine-specific emergency instructions supplied with the prescribed product.

In India, call 112 for immediate emergency assistance. Nily is not an emergency-monitoring service.

Read Nily's Safety Guidance

Pregnancy, breastfeeding and reproductive planning

The automated GLP-1 pathway must hard-stop medicine conversion when a user reports pregnancy, breastfeeding or current pregnancy planning and direct the person to appropriate professional guidance. Nily must not provide a medication start, continuation, stopping interval or contraception instruction through public content.

If pregnancy occurs or is suspected while using prescribed medicine, contact the prescribing professional promptly and follow current product-specific advice. Do not make an independent medication change solely from this page.

Cost and access should be transparent

The total pathway can involve different components: consultation, medicine, laboratory testing, nutrition support, program access and follow-up. Nily must show the current price and scope of each component before purchase.

Do not advertise a token consultation price as the cost of treatment, publish stale medicine prices or use "limited prescription slots." Medicine availability and price can change and must be verified at the applicable licensed fulfilment step.

Pricing

The app is free forever — pay only for the program you choose

  • Start free — the Nily app, your daily check-ins and tracking cost nothing
  • No card, no catch to begin
  • Premium features live in one optional Nily PRO, when you want more

You only ever pay for what you choose — every price is shown before you buy.

256-bit AES encryption at rest · TLS in transit. Your health data never leaves the people you trust.

Use the Metabolic Care Cost Planner

Privacy around prescription interest and medication data

Interest in GLP-1 treatment, current medicine, symptoms, weight, assessment answers, pregnancy information and prescriber communications are sensitive. They must not become advertising audiences, sales-lead scores or remarketing triggers.

If you save a result or join the program, Nily should explain what is stored, why, who can access it and how to exercise available choices.

Email is not an emergency channel and must not be used for dose or urgent-symptom advice.

Want the fuller picture first? See how Nily works or browse all health services.

Related metabolic and GLP-1 pathways

Metabolic health hub

Start from broader metabolic context—weight, blood sugar risk, appetite and energy—before assuming GLP-1 medicine is the right path.
Explore Metabolic Health Take the Metabolic Health Assessment

Medical weight management

A doctor-led weight-management pathway that does not treat medicine as the default outcome. Explore Medical Weight Management

GLP-1 clinical evaluation

The pre-prescription professional consultation this program's readiness check leads into. Explore Clinical Evaluation

Frequently asked questions

What is a GLP-1 support program?

It is a structured pathway for consultation preparation, prescribed-plan adherence, daily routines, symptom recording and follow-up preparation. It does not replace the prescriber or independently manage medicine.

Does Nily prescribe GLP-1 medicine?

Nily's public tools and program do not prescribe. Where an applicable consultation service is available, only an appropriately qualified prescriber may determine whether any prescription is clinically and legally appropriate.

Does the readiness checker confirm eligibility?

No. It organizes information for a possible professional conversation. It cannot confirm suitability, approve a medicine or guarantee a prescription.

Does joining guarantee access to semaglutide, tirzepatide or another medicine?

No. Product indication, suitability, authorization, availability and price can differ and change. A qualified prescriber must evaluate the individual, and fulfilment must follow applicable requirements.

Can Nily tell me which GLP-1 medicine is best?

No automated Nily result should select a medicine. The decision requires individual clinical assessment and current medicine-specific information.

Can Nily tell me when to increase my dose?

No. Dose and titration decisions belong to the prescribing professional. Follow the written plan and contact the prescriber when instructions are unclear or symptoms occur.

What is medication adherence?

Medication adherence means taking a prescribed medicine exactly as directed—correct product, dose, timing and schedule—and recording missed or delayed doses accurately. Nily’s adherence tracking builds a clearer record for follow-up; it does not decide whether a dose or product should change, which remains the prescriber’s decision.

What if I miss or repeat a dose?

Do not rely on a generic website answer because instructions can differ by product and circumstances. Review the authorized product information and contact the prescriber or pharmacist for individualized guidance.

Will I lose a guaranteed amount of weight?

No. Outcomes vary with medicine, dose, starting health, biology, adherence, tolerability, routines and other factors. Nily does not guarantee a number or timeline.

Do I need laboratory tests?

The need for testing depends on individual context, current reports, medicine and professional judgment. Nily must not make one test bundle mandatory for every user through marketing copy.

Can I use the program if I have diabetes?

The program may support tracking around an existing professional plan, but do not change diabetes medicine or monitoring based on Nily content. Disclose all current treatment to the applicable prescriber.

Can I use GLP-1 medicine during pregnancy or breastfeeding?

This public page does not provide medicine-use advice for pregnancy or breastfeeding. The automated pathway must stop medication conversion and direct the person to prompt, product-specific professional guidance.

Can I buy the medicine directly from Nily?

This page does not promise direct medicine sale or availability. Any prescription fulfilment must use a valid prescription, an appropriately licensed channel and current product and pricing information.

Is the program available across India?

Digital support may be accessible nationally, but consultation, testing and fulfilment availability can vary. Serviceability must be confirmed before payment.

How can I contact Nily?

For support or privacy questions, email care@nily.health. For business or partnership enquiries, email Info@annotatory.com.

Build support around the prescription—not pressure around the sale

Start by organizing the context for a qualified conversation. If treatment is prescribed, use Nily to maintain a clearer daily record and prepare for follow-up.

Check GLP-1 Consultation Readiness Explore GLP-1 Clinical Evaluation

Nily does not guarantee a prescription, medicine, dose, refill, availability or health outcome. Questions? Email care@nily.health.